AMPAC Fine Chemicals Adds New Capabilities For Clinical Programs
RANCHO CORDOVA, Calif., Feb. 8, 2011 /PRNewswire/ -- AMPAC Fine Chemicals LLC (AFC), a wholly owned subsidiary of American Pacific Corporation (Nasdaq: APFC), announced it has completed substantial plant capital improvements by adding a second semi-works facility. These capital improvements are part of several capital improvements in progress at AFC's operations in Rancho Cordova through FY 2011. This semi-works facility became fully operational in January 2011 and is being used to support continued growth in AFC's development pipeline.
This facility offers a state of the art, remotely operable facility that is designed to safely run hydrogenations, hazardous chemistry and potent compound processes, core technologies for AFC. Equipment consists of four reactors (from 300-750 gal) and one 2.0 m2 Hastelloy filter-dryer. AFC completed its first semi-works facility at its Rancho Cordova location in 2008. Robust customer demand has resulted in the construction of this second semi-works unit.
"AFC continues to increase the assets and resources to support a strong pipeline of development projects from a variety of large pharma and biotechnology companies. Our goal is to build upon our core technologies, including energetic chemistry, continuous processing, HPAPIs, and simulated moving bed (SMB) chromatography to grow our business and help our clients. This latest investment further increases our capabilities to serve this vibrant market," stated Bill DuBay, VP of Technology and Business Development.
"AMPAC Fine Chemicals continues to actively invest in our facilities which are all located in the USA. We are pleased that our pipeline of development projects continues to grow and this addition will help us meet our customer requirements," stated Aslam Malik, President of AFC."As a leading manufacturer of custom Active Pharmaceutical Ingredients, AFC will increase their ability to provide value to our customers through these additional capital investments," stated Joe Carleone, Chief Executive Officer of AMPAC. ABOUT AMPAC FINE CHEMICALS LLC AFC is a U.S.-based company with demonstrated capabilities in process development, scale-up, and cGMP-compliant commercial production of active pharmaceutical ingredients (API's) and registered intermediates for pharmaceutical and biotechnology customers. Its specially engineered facilities and experienced staff allow AFC to safely produce highly energetic compounds at commercial scale. In addition, AFC's other technology platforms include production of highly potent compounds, continuous processes and industrial-scale chromatographic separation using simulated moving bed chromatography (SMB). AFC's operations are located in Rancho Cordova, CA and in La Porte, Texas. ABOUT AMERICAN PACIFIC CORPORATION American Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets. We supply active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry. For the aerospace and defense industry we provide specialty chemicals used in solid rocket motors for space launch and military missiles. AMPAC also designs and manufactures liquid propulsion systems, valves and structures for space and missile defense applications. We produce clean agent chemicals for the fire protection industry, as well as electro-chemical equipment for the water treatment industry. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. Additional information about us can be obtained by visiting our web site at www.apfc.com. SOURCE American Pacific Corporation
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.